> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 7-Item 483 Issued to ACRX Specialty
- URL: https://www.fdaweb.com/7-item-483-issued-to-acrx-specialty/
- Published: 2021-11-05T12:00:00.000Z
- Updated: 2026-09-14T17:21:35.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5150526

FDA has issued a seven-item [Form FDA-483](https://www.fda.gov/media/153655/download?ref=fdaweb.com) to ACRX Specialty (Las Vegas, NV) after inspecting the firm in July and finding GMP issues. For example, FDA said the firm’s ISO 5-classified aseptic processing areas had visibly dirty equipment or surface areas. It also found non-microbial contamination in the production area. Additionally, the firm produced drug products with materials that had not been verified to assure that they did not contribute to endotoxin contamination that may be objectionable given the product’s intended use.